Importance of nanoparticles in breast cancer therapy
Author:
Kaur Navpreet1, Bhaskar Pranav2
Affiliation:
1. Department of Medical Laboratory Technology, Goswami Ganesh Dutta Sanatan Dharma College, Chandigarh, India. 2. Department of Biochemistry, Panjab University, Chandigarh - 160014, India
Abstract
Despite significant advancements in the field of breast cancer therapy (such as chemotherapy or radiotherapy), still, several women fail while having these treatments and die. To overcome certain side effects, nanoparticles (NPs) proved to be a powerful tool as drug delivery vehicles. The major factors that contribute to achieving this target include small size, more drug accumulation, non-toxicity, efficiency, bioavailability, and studies such as optimum pH, temperature, drug release profile, cytotoxicity tests, etc. The arena of nanotechnology has allowed countless researchers to address the role of NPs in the delivery of numerous drugs into breast cancer cells. The NPs synthesized by any of the methods can be tuned to various sizes and shapes. They can also be modified with chemical reagents to contain certain functional groups followed by linkage to drugs via covalent or non-covalent interactions. The present chapter is focused on types of NPs - properties and challenges which are in use for breast cancer therapy. The reported studies clearly indicate that NPs have prospective importance in the controlled release of drugs and refining the lifespan of patients.
Publisher
The Applied Biology & Chemistry Journal
Subject
Community and Home Care,Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology,General Medicine,General Medicine,General Medicine,General Medicine,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Earth and Planetary Sciences,General Environmental Science,General Medicine
Reference34 articles.
1. Abu Lila, A.S., Soliman, M.S., Kiran, H.C., Gangadharappa, H. V, Younes, K.M., Khafagy, E., et al. (2021). Tamoxifen-loaded functionalized graphene nanoribbons for breast cancer therapy. Journal of Drug Delivery Science and Technology, 63, 102499. https://doi.org/10.1016/j.jddst.2021.102499 2. Al-dulimi, A.G., Al-saffar, A.Z., Sulaiman, G.M., Khalil, K.A.A., Khashan, K.S., Al-shmgani, H.S.A., & Ahmed, E.M. (2020). Immobilization of L -asparaginase on gold nanoparticles for novel drug delivery approach as anti-cancer agent against human breast carcinoma cells. Journal of Materials Research and Technology, 9, 15394–15411. https://doi.org/10.1016/j.jmrt.2020.10.021 3. Aragay, G., Pino, F., & Merkoci, A. (2012). Nanomaterials for sensing and destroying pesticides. Chemical Reviews, 112, 5317–5338. https://doi.org/10.1021/cr300020c 4. Basu, A., Upadhyay, P., Ghosh, A., Bose, A., & Gupta, P. (2021). Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer. BBA - General Subjects, 1865, 129841, https://doi.org/10.1016/j.bbagen.2020.129841 5. Cai, S., Thati, S., Bagby, T.R., Diab, H., Davies, N.M., Cohen, M.S., & Forrest, M.L. (2010). Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. Journal of Controlled Release, 146, 212–218. http://dx.doi.org/10.1016/j.jconrel.2010.04.006
|
|